1.
J Nat Prod
; 65(1): 51-3, 2002 Jan.
Article
in English
| MEDLINE
| ID: mdl-11809064
ABSTRACT
The Indonesian red alga Vidalia sp. was identified as a candidate for fractionation because its crude lipid extract showed activity in a mechanism-based anticancer assay (Fyn SH2-inhibitory activity). A chemically novel phenolic metabolite, vidalenolone, as well as two previously described and structurally simple phenols, were isolated as SH2-inactive substances. Their structures were determined by an interplay of spectroscopic methods, principally 2D NMR, and reference to literature data.